Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia

Table 3

Adverse events.

	Any grade number (%)	≥grade 3 number (%)
Increased AST/ALT levels	24 (75)	9 (28)
Pain	19 (59)	0
Increased ALP level	15 (46)	0
Ascites	14 (44)	0
Increased bilirubin level	11 (34)	2 (6)
Anorexia	6 (19)	0
Pleural effusion	5 (16)	0
Fever	4 (13)	0
Decreased leukocyte counts	3 (9)	2 (6)
Increased PT-INR	3 (9)	2 (6)
Hyperkalemia	3 (9)	1 (3)
Hypocalcemia	3 (9)	0
Constipation	3 (9)	0
Increased CPK level	3 (9)	0
Decreased neutrocyte counts	2 (6)	2 (6)
Hyperuricemia	2 (6)	1 (3)
Nausea	2 (6)	0
Diarrhea	2 (6)	0
Hematoma	2 (6)	0
Increased creatinine level	2 (6)	0
Hepatic failure	1 (3)	1 (3)
Portal vein thrombosis	1 (3)	1 (3)
Splenic abscess	1 (3)	0
Splenic rupture	0	0
Pneumonia	0	0

AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; PT-INR, prothrombin time-international normalized ratio; CPK, creatine phosphokinase.